The Future of the Home Healthcare Equipment Market to 2016 - Market Forecasts, Competitive Landscape and Pipeline Analysis by GBIResearch

VIEWS: 385 PAGES: 85

The Future of the Home Healthcare Equipment Market to 2016 - Market Forecasts, Competitive Landscape and Pipeline Analysis

Summary

GBI Research’s report, “The Future of the Home Healthcare Equipment Market to 2016 - Increasing Awareness Driving Demand” provides key data, information and analysis on the global home healthcare equipment market. The report provides market landscape, competitive landscape and market trends information on seven home healthcare equipment market segments – glucose monitoring systems, insulin delivery devices, inhalation systems, hematology rapid tests, automatic sphygmomanometers and remote patient monitoring. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape, key pipeline products and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Scope

- Key geographies covered include the US (United States), Canada, the UK (United Kingdom), Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Market size and company share data for seven home healthcare equipment market categories – glucose monitoring systems, insulin delivery devices, inhalation systems, hematology rapid tests, automatic sphygmomanometers and remote patient monitoring.
- Annualized market revenues data from 2002 to 2009, forecast forward for 7 years to 2016. Company shares data for 2008
- Qualitative analysis of key market trends, market drivers, and restraints by each category within the home healthcare equipment market.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.

Reasons to buy

- Develop business strategies by understanding the trends and de

More Info
									         The Future of the Home Healthcare Equipment Market to
          2016 - Market Forecasts, Competitive Landscape and
                            Pipeline Analysis
     Reference Code: GBIME0004MR                                                                                            Publication Date: March 2010

  In 2009, the global Home           Global Home Healthcare Equipment market set to boom in the next seven years driven by
  Healthcare Equipment               ageing population
  market size was $40
  billion. It is estimated to        The global home healthcare equipment market was valued at $40,534.6m in 2009 and is forecast
  grow by CAGR 7.4% until            to grow to $66,877m by 2016 at a compound annual growth rate (CAGR) rate of 7.4% in 2009–
  2016 to reach $66.9                2016. The global home healthcare market is forecast to be driven by a growing focus on self-
  billion.                           monitoring to curb spiraling healthcare expenditures due to reimbursement reforms and the
                                     increasing aging population in developed nations. In developing countries, the major drivers for
                                     home healthcare equipment are the increasing incidence of chronic diseases such as asthma,
                                     Chronic Obstructive Pulmonary Disease (COPD) and diabetes, along with growing affordability and
                                     awareness.

                                      Home Healthcare Equipment Market, Global, Revenue ($m), 2009-2016
                                                                    80,000



                                                                    70,000



                                                                    60,000



                                                                    50,000
                                                     Revenue ($m)




                                                                    40,000



                                                                    30,000



                                                                    20,000



                                                                    10,000



                                                                        0
                                                                             2009   2010    2011    2012     2013    2014     2015    2016


                                      Source: GBI Research



                                     Rising Healthcare Expenditure in Developed Nations as Percentage of GDP is Forcing
                                     Healthcare Payers to look for Alternatives
                                     Cost reduction has become the primary theme of healthcare reforms globally. To survive and
                                     succeed in these challenging conditions, it is imperative for healthcare providers to look for ways to
                                     adapt and implement new strategies to help them save on costs. In today’s competitive
                                     environment, reimbursement reforms have made it imperative for providers to perform efficiently
                                     and deliver higher standards of care to become eligible for reimbursements. The paradigm shift
                                     towards improved quality, error free services and the need to ensure patient satisfaction to retain
                                     their allegiance has prompted healthcare providers to adopt novel technologies such as remote
                                     patient monitoring, which relies on self-monitoring in order to reduce costs by reducing the length of
                                     hospital stays. More providers are moving towards remote patient monitoring, which frees up their
                                     physicians and nurses for acute cases and helps them to tackle staff shortages. Acceptance of new
                                     technologies is expected to drastically improve among those who are currently reluctant to invest to
                                     achieve long term cost reduction goals.
                                     GlaxoSmithKline, F. Hoffmann-La Roche Ltd (Roche) and AstraZeneca Dominate the Global
                                     Home Healthcare Equipment Market



The Future of the Home Healthcare Equipment Market to 2016 -                                                            GBIME0004MR /Published MAR 2010
Market Forecasts, Competitive Landscape and Pipeline Analysis
                                                                                                                                                      Page 1
                                                                                       © GBI Research. This is a licensed product and is not to be photocopied
                                     GlaxoSmithKline was the market leader and accounted for 8% of the overall market in 2008.
                                     GlaxoSmithKline has a wide portfolio in metered dose and dry powder inhalers and is also a market
                                     leader in the inhalation systems segment. Roche and AstraZeneca accounted for 7% and 5%
                                     respectively. The global market for home healthcare is quite fragmented due to the presence of a
                                     number of small local players, which account for nearly 50% of the total market.

                                     Home Healthcare Equipment Market, Global, Company Share (%),2008

                                                                       GlaxoSmithKline plc   F. Hoffmann-La Roche
                                                                             8%                       Ltd
                                                                                                      7%
                                                                                                            AstraZeneca
                                                                                                             International
                                                                                                                  5%

                                                                                                                   LifeScan, Inc.
                                                                                                                        4%
                                                                                                                      Bayer HealthCare
                                                                                                                            3%

                                                                                                                         Novartis
                                                                                                                           3%
                                                                                                                      Boehringer Ingelheim
                                                                                                                              3%
                                                       Others
                                                                                                                        Sepracor 3%
                                                        49%
                                                                                                                      Abbott 2%
                                                                                                                     Medtronic, Inc.
                                                                                                                          2%
                                                                                                               3M Health Care
                                                                                                                    2%
                                                                                                           Becton Dickinson
                                                                                                                  2%
                                                                        Omron Healthcare Co.,
                                                                               Ltd.                      William Demant Holding
                                                                                1%                                 A/S
                                                                                           Phonak Holding AG       2%
                                                                                                  2%

                                     Source: GBI Research



                                     Markets such as inhalation systems are dominated by generic players. However, due to the
                                     phasing out of chlorofluorocarbons (CFCs) in most developed countries, it is expected that the
                                     market share of players such as GlaxoSmithKline and AstraZeneca will rise in the future, since
                                     there are no generics for the alternatives. Other significant players in the home healthcare market
                                     are glucose meter manufacturers such as Roche, LifeScan, and Bayer. A significant trend is the
                                     entry of telecom and IT services companies such as Verizon, Alcatel Lucent and Intel into the
                                     remote patient monitoring market. These companies are leveraging their expertise in areas such as
                                     networking and data security to deliver healthcare solutions to providers.
                                     Innovations in Ease-of-use and Performance to Accelerate Adoption of Home Healthcare
                                     Devices
                                     The home healthcare market is a consumer driven market, where the product’s success hinges
                                     upon the ease of use and the associated the learning curve. Medical device manufacturers are
                                     increasingly recognizing this, and are now including small but significant design changes which fit
                                     into a patient’s routine rather than other way around. Home monitoring devices have become
                                     smaller and more unobtrusive, and in some cases do not even require removal during bathing and
                                     sleeping. These changes allow patients to maintain their current lifestyle, indirectly increasing
                                     compliance by reducing the adjustments one had to make with traditional systems.
                                     A number of technologies have now enhanced the reliability of testing within the home monitoring
                                     devices and have led to rapid adoption by patients and healthcare providers alike. Current
                                     marketed glucose meters have to meet accuracy standards set by the International Organization
                                     for Standardization (ISO). This standardization has resulted in wider patient acceptance of self-
                                     monitoring blood glucose meters. A large number of hospitals have started using glucose meters
                                     for determining glucose levels. New blood pressure monitors are now designed to compensate for
                                     the discrepancies that crop up due to changes in body movements or irregular heart beats.
                                     These technological advances are changing the perceptions of consumers and are expected to
                                     enhance the acceptance of home monitoring devices among patients in the future.



The Future of the Home Healthcare Equipment Market to 2016 -                                                      GBIME0004MR /Published MAR 2010
Market Forecasts, Competitive Landscape and Pipeline Analysis
                                                                                                                                             Page 2
                                                                       © GBI Research. This is a licensed product and is not to be photocopied
                                     1         Table of Contents
                                     1      Table of Contents .................................................................................................................... 3
                                         1.1      List of Tables.................................................................................................................. 6
                                         1.2      List of Figures................................................................................................................. 7
                                     2      Introduction .............................................................................................................................. 8
                                         2.1      GBI Research Guidance ................................................................................................ 8
                                     3      Global Home Healthcare Equipment Overview........................................................................ 9
                                     4      Global Home Healthcare Equipment: Market Characterization.............................................. 10
                                         4.1      Global Home Healthcare Equipment Market, Revenues ($m), 2002 – 2009................ 10
                                         4.2      Global Home Healthcare Equipment Market, Revenue Forecasts ($m), 2009 – 2016. 11
                                         4.3      Global Home Healthcare Equipment Market, Key Company Shares (%), 2008........... 12
                                         4.4      Global Home Healthcare Equipments, Key Market Trends .......................................... 13
                                            4.4.1     Entry of Telecom and IT Companies in Telemedicine to boost Remote Patient
                                                      Monitoring................................................................................................................ 13
                                            4.4.2     Most Countries Working Towards Phasing Out Of CFC Containing Inhalers .......... 14
                                         4.5      Global Home Healthcare Devices: Key Technology Trends......................................... 14
                                            4.5.1     Innovations to Target Expediency Driven Consumers for Home Monitoring ........... 14
                                            4.5.2     Technological Advancements Which Improve Performance of Home Monitoring
                                                      Devices.................................................................................................................... 15
                                            4.5.3     Wireless Revolution in Home Patient Monitoring..................................................... 15
                                         4.6      Global Home Healthcare Equipment, Market Drivers................................................... 17
                                            4.6.1     Economic Market Drivers ........................................................................................ 17
                                            4.6.2     Technology Drivers.................................................................................................. 19
                                            4.6.3     Social Drivers .......................................................................................................... 20
                                         4.7      Global Home Health Monitoring, Market Restraints ..................................................... 21
                                            4.7.1     Economic Market Restraints.................................................................................... 21
                                            4.7.2     Technology Restraints............................................................................................. 21
                                     5      Global Home Healthcare Equipment: Market Category Analysis and Forecasts ................... 22
                                         5.1      Glucose Monitoring Devices: Market Characterization................................................. 22
                                            5.1.1     Global Glucose Monitoring Devices Market, Revenues ($m), 2002–2009 .............. 22
                                            5.1.2     Global Glucose Monitoring Devices Market, Revenue Forecasts ($m), 2009–2016 23
                                            5.1.3     Global Glucose Monitoring Devices Market, Key Company Shares (%), 2008 ....... 24
                                            5.1.4     Glucose Monitoring Market: Market Drivers ............................................................ 25
                                            5.1.5     Glucose Monitoring Market: Market Restraints........................................................ 26
                                         5.2      Insulin Delivery Market: Market Characterization ......................................................... 28
                                            5.2.1     Global Insulin Delivery Market, Revenues ($m), 2002 – 2009................................. 28
                                            5.2.2     Global Insulin Delivery Market, Revenue Forecasts ($m), 2009 – 2016.................. 29
                                            5.2.3     Global Insulin Delivery Market, Key Company Shares (%), 2008............................ 30
                                            5.2.4     Insulin Delivery Market: Market Drivers ................................................................... 31
                                            5.2.5     Insulin Delivery Market: Market Restraints .............................................................. 32
                                         5.3      Inhalation Systems Market: Market Characterization ................................................... 33
                                            5.3.1     Global Inhalation Systems Market, Revenues ($m), 2002 – 2009........................... 33
                                            5.3.2     Global Inhalation Systems Market, Revenue Forecasts ($m), 2009 – 2016............ 34
                                            5.3.3     Global Inhalation Systems Market, Key Company Shares (%), 2008...................... 35
                                            5.3.4     Inhalation Systems Market: Market Drivers ............................................................. 35
                                            5.3.5     Inhalation Systems Market: Market Restraints ........................................................ 36
                                         5.4      Hearing Aids Market: Market Characterization............................................................. 37
                                            5.4.1     Global Hearing Aids Market, Revenue ($m), 2002 – 2009 ...................................... 37
                                            5.4.2     Global Hearing Aids Market, Revenue Forecasts ($m), 2009 – 2016 ..................... 38
                                            5.4.3     Global Hearing Aids Market, Key Company Shares (%), 2008 ............................... 39
                                            5.4.4     Hearing Aids Market: Market Drivers....................................................................... 40
                                            5.4.5     Hearing Aids Market: Market Restraints .................................................................. 40
                                         5.5      Automatic Sphygmomanometer Market: Market Characterization ............................... 41
                                            5.5.1     Global Automatic Sphygmomanometer Market, Revenues ($m), 2002 – 2009....... 41


The Future of the Home Healthcare Equipment Market to 2016 -                                                                         GBIME0004MR /Published MAR 2010
Market Forecasts, Competitive Landscape and Pipeline Analysis
                                                                                                                                                                               Page 3
                                                                                        © GBI Research. This is a licensed product and is not to be photocopied
                                             5.5.2   Global Automatic Sphygmomanometer Market, Revenue Forecasts ($m),
                                                     2009 – 2016............................................................................................................. 42
                                            5.5.3    Global Automatic Sphygmomanometer Market, Key Company Shares (%), 2008.. 43
                                            5.5.4    Global Automatic Sphygmomanometer Market: Market Drivers.............................. 44
                                            5.5.5    Global Market Restraints Automatic Sphygmomanometer Market: Market Restraints
                                                      ................................................................................................................................ 45
                                         5.6      Remote Monitoring Market: Market Characterization ................................................... 46
                                            5.6.1    Global Remote Monitoring Market, Revenues ($m), 2002 – 2009........................... 46
                                            5.6.2    Global Remote Monitoring Market, Revenue Forecasts ($m), 2009 – 2016............ 47
                                            5.6.3    Global Remote Monitoring Market, Key Company Shares (%), 2008...................... 48
                                            5.6.4    Global Remote Monitoring Market: Market Drivers.................................................. 48
                                            5.6.5    Global Remote Monitoring Market: Market Restraints ............................................. 50
                                     6      Global Home Healthcare Equipment: Strategic Competitive Assessment ............................. 52
                                         6.1      Key Market Participants ............................................................................................... 52
                                            6.1.1    F. Hoffmann-La Roche Ltd ...................................................................................... 52
                                            6.1.2    AstraZeneca ............................................................................................................ 53
                                            6.1.3    LifeScan .................................................................................................................. 53
                                            6.1.4    Abbott Laboratories ................................................................................................. 54
                                            6.1.5    GlaxoSmithKline ...................................................................................................... 55
                                            6.1.6    Medtronic................................................................................................................. 55
                                            6.1.7    Becton, Dickinson and Company ............................................................................ 57
                                            6.1.8    Boehringer Ingelheim .............................................................................................. 57
                                     7      Global Home Healthcare Equipment: Product Pipeline Analysis ........................................... 59
                                         7.1      Pipeline Products by Category ..................................................................................... 59
                                            7.1.1    Pipeline Products By Segment: Glucose Monitoring ............................................... 60
                                            7.1.2    Pipeline Products By Segment: Insulin Delivery...................................................... 61
                                         7.2      List of Pipeline Products............................................................................................... 62
                                         7.3      Key Pipeline Products .................................................................................................. 68
                                            7.3.1    Glucose Monitoring ................................................................................................. 68
                                            7.3.2    Insulin Delivery ........................................................................................................ 69
                                            7.3.3    Inhalation Systems .................................................................................................. 70
                                            7.3.4    Hearing Aid Devices ................................................................................................ 71
                                            7.3.5    Automatic Sphygmomanometer .............................................................................. 72
                                            7.3.6    Remote Patient Monitoring ...................................................................................... 72
                                     8      Global Home Healthcare Equipment Market: Consolidation Landscape................................ 74
                                         8.1      Deals by Type, 2006 – 2009 ........................................................................................ 74
                                         8.2      Deals by Value and Volume, 2006 – 2009 ................................................................... 75
                                         8.3      Key Mergers and Acquisitions, 2006–2009 .................................................................. 75
                                            8.3.1    Dainippon Sumitomo Pharma Completes Acquisition of Sepracor for $2.6 Billion .. 75
                                            8.3.2    3M Acquires Aearo Technologies From Permira..................................................... 76
                                            8.3.3    Technitrol Acquires Sonion...................................................................................... 76
                                            8.3.4    Sonova Holding Completes Acquisition Of InSound Medical .................................. 76
                                            8.3.5    Bayer HealthCare Diabetes Care Acquires Metrika ................................................ 77
                                            8.3.6    Ypsomed Holding Acquires 10% Equity Stake in BIONIME .................................... 77
                                            8.3.7    Derwood Chase and Michael Stewart Acquires Zounds.......................................... 77
                                            8.3.8    Mediscience Technology Acquires SensiVida Medical Systems ............................. 77
                                            8.3.9    Sontra Medical Merges with Echo Therapeutics ..................................................... 77
                                            8.3.10        Sonomax Hearing Sells VitaSound To Trivaris................................................... 78
                                            8.3.11        Robert Bosch Acquires Health Hero Network..................................................... 78
                                            8.3.12        Omron Healthcare Acquires Colin Medical Instruments ..................................... 78
                                            8.3.13        GE Healthcare Acquires Living Independently Group......................................... 78
                                            8.3.14        ConvaTec Acquires Unomedical Holding ........................................................... 79
                                            8.3.15        Bayer HealthCare Completes Acquisition Of iSense .......................................... 79
                                     9      Appendix................................................................................................................................ 80
                                         9.1      Definitions .................................................................................................................... 80


The Future of the Home Healthcare Equipment Market to 2016 -                                                                         GBIME0004MR /Published MAR 2010
Market Forecasts, Competitive Landscape and Pipeline Analysis
                                                                                                                                                                               Page 4
                                                                                        © GBI Research. This is a licensed product and is not to be photocopied
                                           9.1.1      Glucose Monitoring ................................................................................................. 80
                                           9.1.2      Insulin Delivery ........................................................................................................ 80
                                           9.1.3      Inhalation Systems .................................................................................................. 81
                                           9.1.4      Hearing Aid Devices ................................................................................................ 81
                                           9.1.5      Patient Monitoring ................................................................................................... 81
                                        9.2        Acronyms ..................................................................................................................... 82
                                        9.3        Methodology................................................................................................................. 82
                                           9.3.1      Secondary Research ............................................................................................... 83
                                           9.3.2      Primary Research.................................................................................................... 83
                                           9.3.3      Models..................................................................................................................... 84
                                           9.3.4      Expert Panels .......................................................................................................... 84
                                        9.4        Contact Us ................................................................................................................... 84
                                        9.5        Disclaimer .................................................................................................................... 85




The Future of the Home Healthcare Equipment Market to 2016 -                                                                     GBIME0004MR /Published MAR 2010
Market Forecasts, Competitive Landscape and Pipeline Analysis
                                                                                                                                                                           Page 5
                                                                                     © GBI Research. This is a licensed product and is not to be photocopied
                                     1.1     List of Tables
                                     Table 1:     Home Healthcare Equipment Market, Global, Revenue ($m), 2002-2009 ................... 10
                                     Table 2:     Home Healthcare Equipment Market, Global, Revenue ($m), 2009-2016 ................... 11
                                     Table 3:     Home Healthcare Equipment, Global, Company Share ($m), 2008............................. 12
                                     Table 4:     Population of Above 65 Years, Top 12 Countries, 2015 .............................................. 20
                                     Table 5:     Glucose Monitoring Devices Market, Global, Revenues ($m), 2002–2009 .................. 22
                                     Table 6:     Glucose Monitoring Devices Market, Global, Revenue ($m), 2009–2016 .................... 23
                                     Table 7:     Glucose Monitoring Devices Market, Global, Company Share ($m),2008 ................... 24
                                     Table 8:     Diabetes Prevalence By Region, 2010–2030............................................................... 25
                                     Table 9:     Insulin Delivery Market, Global, Revenues ($m), 2002–2009 ...................................... 28
                                     Table 10:    Insulin Delivery Market, Global, Revenue ($m), 2009–2016 ........................................ 29
                                     Table 11:    Insulin Delivery Market, Global, Company Share ($m), 2008....................................... 30
                                     Table 12:    Diabetes mellitus Type 1 Incidence and Diabetic Population By Country, 2010 .......... 31
                                     Table 13:    Inhalation Systems Market, Global, Revenues ($m), 2002–2009 ................................ 33
                                     Table 14:    Inhalation Systems Market, Global, Revenue ($m), 2009–2016 .................................. 34
                                     Table 15:    Inhalation Systems Market, Global, Company Share ($m),2008.................................. 35
                                     Table 16:    Hearing Aids Market, Global, Revenue ($m), 2002–2009 ............................................ 37
                                     Table 17:    Hearing Aids Market, Global, Revenue ($m), 2009–2016 ............................................ 38
                                     Table 18:    Hearing Aids Market, Global, Company Share ($m),2008 ........................................... 39
                                     Table 19:    Automatic Sphygmomanometer Market, Global, Revenue ($m), 2002–2009 .............. 41
                                     Table 20:    Automatic Sphygmomanometer Market, Global, Revenue ($m), 2009–2016 .............. 42
                                     Table 21:    Automatic Sphygmomanometer Market, Global, Company Share ($m),2008.............. 43
                                     Table 22:    Remote Monitoring Market, Global, Revenue ($m), 2002–2009 .................................. 46
                                     Table 23:    Remote Monitoring Market, Global, Revenue ($m), 2009–2016 .................................. 47
                                     Table 24:    Remote Monitoring Market, Global, Company Share (%),2008 ................................... 48
                                     Table 25:    Home Healthcare Equipment , Pipeline Products, Roche, 2010 .................................. 53
                                     Table 26:    Home Healthcare Equipment, Pipeline Products, Medtronic, 2010.............................. 56
                                     Table 27:    Home Healthcare Equipment, Pipeline Products, Boehringer Ingelheim, 2010............ 58
                                     Table 28:    Home Healthcare Equipment, Global, No. of Pipeline Products, by Category ............. 59
                                     Table 29:    Glucose Monitoring Market, Global, No. of Pipeline Products, by Segment................. 60
                                     Table 30:    Insulin Delivery, Global, No. of Pipeline Products, by Segment ................................... 61
                                     Table 31:    List of Pipeline Products, Home Healthcare Equipment ............................................... 62
                                     Table 32:    Deal Value By Type, Global Home Healthca
								
To top